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Malignantmelanoma is an aggressive tumor, associated with the presence of local
and/or distant metastases. The development of gene therapy by the use of small
interfering RNA (siRNA) represents a promising new treatment. However, the
protection of this biomolecule is necessary in order for it to be intravenously
administrated, for example via its incorporation into nanomedicines. In parallel to
the passive targeting usually obtained by pegylation, various studies have aimed at
developing “smart” nanomedicines to efficiently deliver the drug to tumor sites. In
this work, siRNA loaded lipid nanocapsules (LNCs) were modified with DSPE-
polyethylene glycol (DSPE-PEG), tetraether-PEG (TE-PEG) and/or with an Affitin
model, to assay multiple targeting strategies. The uptake of fluorescently labelled
LNCs, nanocarrier integrity and siRNA release into human SKMel28 melanoma cells
were studied by flow cytometry, conventional confocal microscopy and by confocal
spectral imaging in a Forster Resonance Energy Transfer (FRET) mode. Surface
modified siRNA LNCs were followed after human plasma incubation and after
intravenous injection, in order to compare the stealth properties. Finally, the
biodistribution of the different siRNA LNCs in healthy and melanoma tumor bearing
mice models was assessed by in vivo biofluorescence imaging (BFI), to evaluate the
potential tumor targeting ability. The post-insertion of DSPE-PEG induced a strong
decrease of the internalization into melanoma cells compared to TE-PEG
modification. Both PEG polymer decorations induced a great plasma protection of
siRNA but only DSPE-PEG led to stealth properties, even at low concentration (5
mM). The Affitin grafting by thiolation of DSPE-PEG was validated on siRNA LNCs.
DSPE-PEG-Affitin LNCs were not detected in this melanoma tumor model but did not
show unspecific accumulation in organs. DSPE-PEG and TE-PEG LNCs induced a
significant intratumoral accumulation of modified LNCs.
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